About
We are chemists, physicists, mathematicians, engineers, biologists who work alongside to design bionic units that mimic specific biological functions and/or introduce operations that do not exist in Nature. We apply a constructionist approach where we mimic biological complexity in the form of design principles to produce functional units from simple building blocks and their interactions. We called such an approach: Molecular Bionics.
We are engaged in several activities involving the synthesis and characterisation of novel hierarchal materials whose properties are the result of the holistic combination of its components:
Molecular Engineering
We combine synthetic and supramolecular chemistry to tune inter/intramolecular interactions and self-assembly processes to form dynamic soft materials whose molecular, supramolecular and mesoscale structures are tuned and fit for the final application (pictured right: molecular engineering of nanoscopic structures starting from molecule passing to polymers and finally to supra molecular structures).
Physical Biology
Our materials are designed to interact with living systems and thus its biological activity is studied in high detail. We have developed and established new methodologies to study living systems and how synthetic materials interact with them combining holistically physical and life sciences (Physical Biology).
Synthetic Biology
Both know-hows are applied to study biological organisation and complexity creating synthetic surrogates that act as models, as well as to engineer novel sophisticated ways to interact with living organisms.
Somanautics
In analogy to medical bionics, where engineering and physical science converge to the design of replacement and/or enhancement of malfunctioning body parts, we take inspiration from viruses, trafficking vesicles and exosomes to apply molecular engineering to create nanoscopic carriers that can navigate the human body (Somanautics) with the final aim to improve drug delivery or create new diagnostic tools.
Visit our external website to find out more.
Staff
Giuseppe Battaglia
ibecbarcelona.euProjects
| INTERNATIONAL GRANTS | FINANCER | PI |
|---|---|---|
| CheSSTag · Chemotactic Super-Selective Targeting of Gliomas (2020-2023) | European Comission / ERC-CoG | G. Battaglia |
| NATIONAL PROJECTS | FINANCER | PI |
|---|---|---|
| BrainPePN · Nanomedicinas de precisión que penetran el cerebro (2021-2024) | MICIU / Retos investigación: Proyectos I+D | G. Battaglia |
| FUNDRAISING PROJECTS | FINANCER | PI |
|---|---|---|
| A por la COVID-19 (2021-2022) | IBEC / Faster Future 2020 | G. Battaglia |
Publications
Check for more detailed information on the outputs of the Group at IBEC CRIS portal.
Publications list:
Equipment
- State-of-the-art facilities for cell culture including 5 class A cell cabinets: one dedicated for LPS and RNAse free cell culture and one dedicated for infected tissues
- Fluorescence Activated Cell Sorting (FACS)
- Confocal microscope to perform live cell 4D imaging
- Thermocycler
- Real-time PCR
- Automated Western Blot
- Gel Permeation Chromatography
- High-Performance Liquid Chromatography
- Ultra Performance Liquid Chromatography equipped with fluorescence, UV/Vis and Infrared and light scattering detectors
- Dynamic light scattering unit
- Nanoparticle tracking analysis
- UV and Fluorescence spectroscopy
- Automated liquid handling units
- Nanoparticle production units
Collaborations
- Xavier Salvatella
IRB Barcelona - Francesca Peiro
Physics-University of Barcelona - Kostas Kostarellos
Life Science- University of Manchester/ICN2 - Giorgio Volpe
Chemistry-UCL - Simona Parrinello
Cancer Institute -UCL - Finn Werner
Structural Biology -UCL - Nick Lane
Evolutionary Biology -UCL - Darren Hargraves
Pediatric Neuro-Oncology -UCL - Timothy McHugh
Clinical Microbiology =UCL - Sebastian Brander
Neurology -UCL - Joan Abbott
Physiology -King’s College London - Molly Stevens
Bioengineering -Imperial College London - Stefano Angioletti-Uberti
Materials Science -Imperial College London - Ricardo Sapienza
Physics -Imperial College London - Daan Frenkel
Chemisty-University of Cambridge - Charlotte Williams
Chemistry -University of Oxford - Francesco Gervasio
Pharmacology -University of Geneve/UCL, UK - Francesco Stellacci
Bionegineering -EPFL Switzerland - Tambet Tessalu
Cancer Biology -University of Tartu (Estonia)/ Sanford Burnham Prebys Medical Discovery Institute - Darrel Irvine
Bioengineering -MIT - Xiaohe Tian
Life Sciences University of Anhui - Yupeng Tian
Chemistry University of Anhui - Lei Luo
Pharmacy -Southwest University, China - Kai Luo
HuaXi hospital Sichuan University - Darren Hargrave
Great Ormond Street Hospital, UCLH London - Sebastian Brander
Queen Square National Centre for Neurology, UCLH London
News
La Razón: Un estudio hispano-chino abre la vía para tratar el alzhéimer con nanotecnología
Diseñan nanopartículas que eliminan los tóxicos que dañan al cerebro y restauran habilidades mentales que parecían perdidas.
L’IBEC, un dels centres seleccionats per la Fundació Pasqual Maragall per als seus ajuts a la recerca
Amayra Hernández-Vega, investigadora sènior de l’IBEC, liderarà un dels dos projectes seleccionats en la convocatòria 2024 del Pasqual Maragall Researchers Programme, dedicada a finançar investigacions sobre l’Alzheimer i altres malalties neurodegeneratives. A més, l’IBEC celebra la participació de Jordi Duran, investigador associat vinculat al grup de Neurobiotecnologia Molecular i Cel·lular de l’institut, com a col·laborador en el segon projecte seleccionat.
NOTICIAS CUATRO: Inyecciones para borrar el Alzheimer
Importante avance médico. Un ensayo científico ha logrado revertir el alzhéimer en ratones a través de una terapia basada en nanotecnología y centrada en el sistema vascular Han logrado una recuperación de las capacidades cognitivas equivalentes a un rejuvenecimiento de unos 20 o 30 años en personas. Declaraciones de Lorena Ruiz Perez, Investigadora del IBEC; Giuseppe Battaglia, Lider Bionica Molecular IBEC.
ARA: Una injecció reverteix símptomesde l’Alzheimer en ratolins
L’administració de nanopartícules permet netejar toxines del cervell
EL PERIÓDICO: Científics de BCN i la Xina reverteixen l’Alzheimer en ratolins
Dissenyen una nova tècnica centrada a restaurar la salut vascular amb injeccions de nanopartícules. «En una hora s’han començat a veure resultats».
Aconsegueixen revertir l’alzheimer en ratolins amb l’ús de nanopartícules
Un equip internacional codirigit per l’Institut de Bioenginyeria de Catalunya (IBEC) i l’Hospital West China de la Universitat de Sichuan (WCHSU) va poder revertir l’Alzheimer en ratolins després de només 3 injeccions amb nanopartícules. L’enfocament innovador per tractar la malaltia se centra a restaurar la funció normal del sistema vascular, en lloc d’actuar sobre les neurones o altres cèl·lules cerebrals, com s’ha fet habitualment fins ara. Aquest assoliment, publicat a la revista Signal Transduction and Targeted Therapy, és un pas prometedor cap a un tractament eficaç per a la malaltia d’Alzheimer.
New York Post: Alzheimer’s breakthrough? Scientists use nanotech to reverse disease in mice
A new study reveals innovative nanotechnology that restored the function of the blood-brain barrier (BBB) to reverse Alzheimer’s in mice.
The Telegraph: Alzheimer’s reversed in mice under breakthrough treatment
Injection of nanoparticles “reminds” blood-brain barrier to work properly, allowing brain cells to communicate again
L’IBEC i IQS acullen la 2a edició del Simposi Barcelona Blood-Brain-Barrier
L’esdeveniment, organitzat conjuntament per l’Institut de Bioenginyeria de Catalunya (IBEC) i l’Institut Químic de Sarrià (IQS), va reunir destacats científics i científiques d’arreu del món per debatre sobre els últims avenços en la recerca de la barrera hematoencefàlica (BBB), des de la seva biologia fonamental fins al seu paper en la malaltia i les estratègies terapèutiques.
L’IBEC liderarà dos projectes biomèdics del programa CaixaImpulse
Anna Lagunas i Daniel Gonzalez-Carter, ambdós investigadors sènior de l’Institut de Bioenginyeria de Catalunya (IBEC), lideraran sengles projectes de la convocatòria 2025 del programa CaixaImpulse. La iniciativa de la Fundació “la Caixa” té com a objectiu accelerar l’arribada al mercat d’innovacions biomèdiques per apropar-les als i les pacients que puguin necessitar-les. Els dos projectes de l’IBEC s’enfoquen en el tractament de malalties que afecten el cervell.
Jobs
Part-time lab manager (Tissue Engineering) in the Molecular Bionics Group (LM_GB)
Ref: LM_GB // Deadline: 31/08/2023
Senior Translational Material Scientist/Chemist at the Molecular Bionics Group (STM_GB)
Ref: STM_GB // Deadline: 31/08/2023
Predoctoral researcher at the Molecular Bionics Research Group
Ref.: PhD-GB // Deadline: 18/02/2023
Senior researcher at the Molecular Bionics Research Group (SRR_GB)
Ref: SRR_GB // Deadline: 16/01/2023
PhD Student at the Molecular Bionics Research Group
Application Deadline: 17/10/2021Ref: PhD_IB The Molecular Bionics group at the Institute for Bioengineering of Catalonia (IBEC) is looking for PhD student to work on the development of targeted nanotherapeutics for drug delivery with a focus on infectious diseases and cancer. The project will be jointly supervised by Dr. Iris L. Batalha (La Caixa Junior Leader Fellow) and Prof. Giuseppe Battaglia. We are looking for a Chemistry/ Bioengineering/ Biotechnology graduate to work on an interdisciplinary project at the interface of chemistry and biology. The project will include the synthesis and functionalisation of polymers and assembly into nanoparticle delivery systems, protein expression and purification, generation of peptide ligands by phage display, and evaluation of targeted nanoparticles in vitro for applications in the treatment of infectious diseases and cancer.